0 avis
Identification of new NMOSD and MOGAD genetic associations
Archive ouverte
Edité par CCSD ; Sage Publications Ltd -
International audience. Introduction: Neuromyelitis Optica Spectrum Disorder (NMOSD) is a severe autoimmune demyelinating disease of the optic nerves and spinal cord affecting 0.4-4/100,000 individuals worldwide. Recently, an international consensus was reached to harmonize diagnosis criteria of neuroinflammatory diseases. The majority of patients with NMOSD are positive for a specific auto-antibody against the astrocytic aquaporin-4 (AQP4) water channel. A separate entity named MOGAD (MOG antibody-associated disease) groups patients with antibodies directed against the myelin oligodendrocyte glycoprotein (MOG). Two studies explored the genomic signature of NMOSD to date: 215 patients vs. 1244 controls from the USA and 203 patients vs. 1782 controls from Japan. They both found SNPs associated with NMOSD (AQP4) risk around HLA-DRB1 gene. However, only a few MOGAD patients were included in these GWASs, consequently, there is no formal GWAS about MOGAD to date.Objectives/Aims: To identify new genetic associations with NMOSD and MOGAD patients.Methods: DNA from 663 NMOSD and MOGAD patients (French NOMADMUS registry) was extracted and genotyped on the PMRA Affymetrix® Axiom chip (900k SNPs). After careful quality controls, we selected 656 patients with high-confidence genotypes.Results: We analyzed the genetic structure using a principal component analysis (PCA) to determine the ancestry of our patients. We could determine that a majority of our samples were of European ancestry (70%). We restricted our study to this population as other ancestries did not bear enough samples to perform a sufficiently powered analysis. We performed a GWAS comparing these patients to 1544 controls from France. We identified a SNP within the HLA class II genomic region to be significantly associated with NMOSD (AQP4) patients (P=1.1x10-9, OR 3.3) which is in line with previous studies. In addition, we found a novel SNP close to the MAP3K7 gene in chromosome 6 showing a suggestive association with MOGAD patients (P=3.9x10-7, OR 3.1).Conclusion: These preliminary results are very promising; however, additional analyses are needed to better describe these associations. We need to perform SNPs imputation to fine-map the genetic associations. We also need to impute the HLA to pinpoint associated HLA alleles, especially in NMOSD AQP4+ patients. This study is of great importance to better understand the genetic interplay between these neuroinflammatory diseases and find clues about their underlying pathophysiological mechanisms.
Consulter en ligne
Suggestions
Du même auteur
